News -
Check out the posts below to learn the latest updates on our progress
- October 19 2020Dr. Sid Kerkar Joins EXUMA Biotech as Vice President Oncology, R&D, Company Presents Data on HER2-Targeting CAR-T at AACR Tumor Immunology and Immunotherapy ConferencePR Newswire
- September 24 2020Speeding the Delivery of CAR-T Therapies While Cutting the Cost
The BIO Report - August 10 2020Expanding Access to CAR-T: Dr. Greg Frost
PharmExec.com - August 3 2020How Big Data Is Accelerating EXUMA Biotech In The Race To Rapid CAR-T Therapy
BioProcess Online - June 16 2020EXUMA Biotech Adds H. Michael Shepard to Scientific Advisory Board and Steven R. Frank to Board of DirectorsPR Newswire
- May 12 2020Let’s Get the CAR-T Started
Longevity Technology - April 15 2020Chairman & CEO Greg Frost on the Empowered Patient podcast with Karen Jagodahttp://empoweredpatientradio.com/
- March 12 2020F1 Oncology Changes Name To EXUMA Biotech; Announces New Round Of Financing To Advance Cellular TherapiesPR Newswire
- April 3 2019Same Day Transduction and In Vivo Expansion of a Chimeric Antigen Receptor with a Synthetic Driver Construct for Adoptive Cellular Therapy
AACR 2019 - April 3 2019A High-Throughput Screening Strategy for the Identification of Novel Lymphoproliferative Elements
AACR 2019